Open Your Free Demat Account
Enjoy low brokerage on delivery trades
Functional & Innovative Foods Limited operates an integrated food contract manufacturing business offering private label and full-service manufacturing across Ready-to-Eat, Ready-to-Cook, staples, sugar alternatives, spices and other allied FMCG products, alongside branded food products marketed through its subsidiary CQFIPL under the "Nallas" brand.
The DRHP highlights key business risks, including dependence on private label and contract manufacturing customers, execution risk on the new manufacturing units being funded from the issue, reliance on subsidiary CQFIPL for branded product revenue, working capital intensity, and competition across the food processing and FMCG contract manufacturing space. Investors should refer to the DRHP and other publicly available information before making an investment decision.
India's food processing industry includes a large base of contract manufacturers that produce private-label goods for retail brands and FMCG companies, alongside operators that also sell under their own brand names. Functional & Innovative Foods Limited operates in both categories, running contract manufacturing for third-party brands and marketing its own branded products through a subsidiary.
Functional & Innovative Foods Limited filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) on June 30, 2026, for an initial public offering (IPO). The company manufactures Ready-to-Eat (RTE), Ready-to-Cook (RTC), staples, sugar alternatives, spices and other allied FMCG products, largely on a private label and full-service contract manufacturing basis for other businesses.
The IPO comprises a fresh issue and an offer for sale, according to the DRHP. This article gives investors a plain summary of the company's operations, financial position, industry presence and business risks, based on the DRHP and publicly reported details.
The table below highlights the key details of the proposed public issue based on information available in the DRHP. Certain details such as the price band, lot size and issue dates are yet to be announced.
| Particulars | Details |
|---|---|
| IPO Type | Book Built Issue |
| IPO Open Date | To be announced |
| IPO Close Date | To be announced |
| Face Value | ₹10 per equity share |
| Price Band | To be announced |
| Lot Size | To be announced |
| Fresh Issue | Up to 60,00,000 equity shares |
| Offer for Sale | Up to 25,00,000 equity shares |
| Listing Exchange | NSE and BSE |
The public issue comprises both a fresh issue and an offer for sale (OFS). The Fresh Issue is for up to 60,00,000 equity shares, and the company will receive these proceeds directly. The OFS comprises up to 25,00,000 equity shares being sold by existing shareholders.
The final price band, issue dates and lot size are yet to be announced. The allocation across investor categories will be announced in the final offer documents subject to SEBI regulations. Not more than 50% of the net offer is reserved for QIBs, not less than 35% for retail investors, and not less than 15% for NIIs.
Functional & Innovative Foods Limited traces its roots to Christy Friedgram Industry, founded in 1989 by T. S. Kumarasamy in Tiruchengode, Tamil Nadu, as the flagship enterprise of the Christy Group. The company's registered office remains in Tiruchengode, Namakkal district, Tamil Nadu. As of December 31, 2025, its product portfolio comprised more than 25 product offerings across more than 700 stock-keeping units (SKUs).
Functional & Innovative Foods operates as an integrated food contract manufacturing company serving businesses ranging from emerging brands to multinational FMCG companies.
Its operations are organised around two areas:
Contract manufacturing, carried out through private label and full-service arrangements, covering end-to-end product development and manufacturing across Ready-to-Eat (RTE), Ready-to-Cook (RTC), staples, sugar alternatives, spices and other allied FMCG products, largely on a B2B basis for Indian and international customers
Branded products, manufactured and marketed through its wholly owned subsidiary, Christy Quality Foods (India) Private Limited (CQFIPL), under the flagship "Nallas" brand, distributed through an extensive network in Tamil Nadu
The company's manufacturing operations run across four manufacturing units comprising nine facilities in Tamil Nadu, with automated systems across material handling, processing and packaging.
Functional & Innovative Foods generates revenue primarily through private label and full-service contract manufacturing arrangements with businesses ranging from emerging brands to multinational FMCG companies.
Its principal revenue streams include:
Ready-to-Eat (RTE) and Ready-to-Cook (RTC) products (47.80% of revenue)
Staples (23.50% of revenue)
Sugar alternatives (18.23% of revenue)
Spices (7.45% of revenue)
Other allied FMCG products (1.79% of revenue)
Packaging (0.36% of revenue)
The company also earns revenue from branded food products sold under the "Nallas" brand through its subsidiary CQFIPL, distributed through an extensive network in Tamil Nadu.
Functional & Innovative Foods operates in India's food contract manufacturing segment, working with customers that range from emerging brands to multinational FMCG companies. Few listed peers in India combine private label contract manufacturing with an owned branded product line in the same manner, which limits direct listed-peer comparison in the DRHP.
The company's four manufacturing units and nine facilities, along with in-house product development capability, position it as a supplier across several FMCG categories rather than a single-product manufacturer.
India's food processing industry has expanded alongside rising demand for convenience foods, packaged staples and health-orientated products. FMCG companies and emerging brands increasingly rely on contract manufacturers to scale production without setting up their own facilities.
Growth drivers for the contract food manufacturing segment include:
Rising demand for Ready-to-Eat and Ready-to-Cook products among urban consumers
FMCG companies outsourcing manufacturing to reduce capital investment
Growth in health-oriented categories such as sugar alternatives and functional foods
Expansion of organised retail and e-commerce distribution for packaged foods
Regulatory emphasis on food safety and quality certification favouring compliant manufacturers
Contract manufacturers depend on the order volumes and category choices of the brands they serve. The DRHP data does not settle how customer concentration affects the company's manufacturing utilisation over time.
This section gives an overview of the business growth, profitability and balance sheet position of Functional & Innovative Foods based on financial performance reported in the DRHP. The table below summarises the key financial parameters on a restated consolidated basis.
| Financials (₹ crore) for period ended on | 31 March 2025 | 31 March 2024 | 31 March 2023 |
|---|---|---|---|
| Total Income | 260.76 | 162.02 | 115.57 |
| EBITDA | 34.47 | 21.46 | 7.17 |
| Profit After Tax | 23.22 | 13.76 | 3.22 |
| Total Assets | 98.46 | 86.29 | 58.45 |
| Net Worth | 27.55 | 26.72 | 12.94 |
| Total Borrowings | 34.40 | 29.64 | 22.77 |
Private label and full-service manufacturing capabilities with repeat customers across FMCG categories.
More than 25 product offerings across more than 700 SKUs spanning RTE, RTC, staples, sugar alternatives and spices.
Four manufacturing units across nine facilities in Tamil Nadu with quality control and supply chain systems in place.
The "Nallas" brand, marketed through subsidiary CQFIPL, gives the company revenue from its own branded products alongside contract manufacturing.
Revenue from private label and contract manufacturing arrangements depends on order volumes from a limited set of brand customers.
Net Proceeds are earmarked for new units at Namakkal, Tamil Nadu, and Dhar, Madhya Pradesh. Execution delays or lower-than-planned utilisation would affect returns on this capital.
Branded product revenue runs through subsidiary CQFIPL. Issue proceeds are also proposed for investment in CQFIPL to repay its borrowings.
The DRHP proposes utilising net proceeds toward long-term working capital requirements, which points to working-capital intensity in the underlying business.
The company competes with other contract manufacturers and branded FMCG players across RTE, RTC, staples, spices and sugar alternatives at the same time.
Manufacturing facilities are concentrated in Tamil Nadu, with the "Nallas" brand distribution network also concentrated in the state.
Before evaluating the IPO, investors may consider the following factors:
Revenue and profit growth across FY2024, FY2025 and the nine months ended December 2025
The mix of private label contract manufacturing versus branded "Nallas" product revenue
Customer concentration within the contract manufacturing business
Utilisation plans for the new Unit-V and Unit-VI capacity being funded from the issue
Planned use of Fresh Issue proceeds as stated in the DRHP, including debt repayment at the company and at CQFIPL
Working capital requirements relative to revenue growth
Competition from other food contract manufacturers and branded FMCG players
The size and sellers in the OFS portion of the issue
Disclaimer :
Investments in securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and/or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited
This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Scan the QR to download the Bajaj Broking App for effortless investing and trading